BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16215887)

  • 1. Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on non-alcoholic steatohepatitis (NASH).
    Gaspari R; Pennisi MA; Mignani V; Gasbarrini A; Mercurio G; Di Campli C; Conti G; Gentiloni Silveri N; Proietti R
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():15-7. PubMed ID: 16215887
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary results of a phase I trial evaluating an extracorporeal hepatic support device utilizing albumin dialysis.
    Awad SS; Swaniker F; Bartlett RH
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():22-3. PubMed ID: 16215890
    [No Abstract]   [Full Text] [Related]  

  • 3. First experience in Spain with MARS in three patients with advanced liver failure.
    Aviles J; Macia M; Perez F; Moreno A; Navarro JF; Morales S; Medina ML; Aguiar R; Garcia J
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():20-1. PubMed ID: 16215889
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of split-liver recipients with poor graft function by albumin-dialysis (Mars).
    Loock J; Treichel U; Gerken G; Malago M; Broelsch C; Philipp T; Heemann U
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():18-9. PubMed ID: 16215888
    [No Abstract]   [Full Text] [Related]  

  • 5. Artificial liver support systems.
    George J
    J Assoc Physicians India; 2004 Sep; 52():719-22. PubMed ID: 15839451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-bound substances--a new target in liver failure therapy.
    Mitzner S; Stange J; Klammt S; Peszynski P; Hickstein H; Korten G; Schmidt R
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():6-7. PubMed ID: 16215882
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term therapy of acute chronic liver failure to successful transplantation with an extracorporeal liver support system.
    Jung O; Asbe-Vollkopf A; Betz C; Caspary W; Geiger H; Faust D
    Z Gastroenterol; 2007 Jan; 45(1):21-4. PubMed ID: 17236117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods of extracorporeal liver support for treatment of liver cell failure.
    Adham M
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():1-5. PubMed ID: 16215880
    [No Abstract]   [Full Text] [Related]  

  • 9. [The clinical experience with MARS and Prometheus procedures].
    Hydzik P; Gawlikowski T; Ciszowski K; Sułlek M
    Przegl Lek; 2007; 64(4-5):352-4. PubMed ID: 17724911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs in liver disease and during albumin dialysis -MARS.
    Majcher-Peszynska J; Peszynski P; Müller SC; Klammt S; Wacke R; Mitzner S; Stange J; Mundkowski R; Hehl EM; Schmidt R; Drewelow B
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():33-5. PubMed ID: 16215894
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC).
    Huster D; Schubert C; Achenbach H; Caca K; Mössner J; Berr F
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():13-4. PubMed ID: 16215886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for extracorporeal liver support as a bridge to liver transplantation in acute liver failure?
    Stutchfield BM; Simpson KJ; Wigmore SJ
    Transplantation; 2011 Oct; 92(8):e44-5. PubMed ID: 21989274
    [No Abstract]   [Full Text] [Related]  

  • 13. [Organ replacement therapy - extracorporeal liver assist devices].
    Sinner B; Kirchner GI
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2016 Sep; 51(9):554-62. PubMed ID: 27631450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin Dialysis as a Bridge From Total Hepatectomy to Liver Transplantation for Fulminant Hepatitis With Toxic Syndrome.
    Levesque E; Azoulay D; Feray C; Dhonneur G
    Ther Apher Dial; 2016 Dec; 20(6):692-693. PubMed ID: 27629817
    [No Abstract]   [Full Text] [Related]  

  • 15. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.
    Stadlbauer V; Krisper P; Beuers U; Haditsch B; Schneditz D; Jung A; Putz-Bankuti C; Holzer H; Trauner M; Stauber RE
    ASAIO J; 2007; 53(2):187-93. PubMed ID: 17413559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non biological artificial devices: what do they mean and what is their role today?].
    Rosa-Diez G; Gadano A
    Acta Gastroenterol Latinoam; 2012 Jun; 42(2):135-44. PubMed ID: 22876717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lean man with nonalcoholic fatty liver disease.
    Tanaka N; Yazaki M; Kobayashi K
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):A32. PubMed ID: 16901765
    [No Abstract]   [Full Text] [Related]  

  • 18. Artificial liver support system using large buffer volumes removes significant glutamine and is an ideal bridge to liver transplantation.
    Inoue K; Kourin A; Watanabe T; Yamada M; Yoshiba M
    Transplant Proc; 2009; 41(1):259-61. PubMed ID: 19249529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Emergency right lobe adult-to-adult live-donor liver transplantation for the treatment of acute liver failure following severe hepatitis].
    Lu SC; Dai J; Wang ML; Zhang Z; Lai W; Wu JS; Lin DD; Guo QL; Li N
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1453-6. PubMed ID: 19094619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Support for the acutely failing liver: a comprehensive review of historic and contemporary strategies.
    Barshes NR; Gay AN; Williams B; Patel AJ; Awad SS
    J Am Coll Surg; 2005 Sep; 201(3):458-76. PubMed ID: 16125082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.